| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/21/1999 | WO1999002689A1 Plant sug1 homologs |
| 01/21/1999 | WO1999002688A1 Coffee storage proteins |
| 01/21/1999 | WO1999002687A1 Method of increasing the iron content of plant cells |
| 01/21/1999 | WO1999002686A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 01/21/1999 | WO1999002684A1 Methods of identifying and screening genes associated with increased longevity and slowed aging |
| 01/21/1999 | WO1999002683A1 Modified lepidopteran receptors and hybrid multifunctional proteins for use in regulation of transgene expression |
| 01/21/1999 | WO1999002682A1 p53 MUTANTS FOUND IN TUMORS |
| 01/21/1999 | WO1999002681A1 Erbb4 receptor-specific neuregulin, related ligands and uses thereof |
| 01/21/1999 | WO1999002680A1 New human growth regulator protein |
| 01/21/1999 | WO1999002679A1 Frazzled nucleotide sequences, expression products, compositions and uses |
| 01/21/1999 | WO1999002678A1 Wa545 compositions |
| 01/21/1999 | WO1999002677A1 Gene originating in human chondrocyte |
| 01/21/1999 | WO1999002676A2 Mutants of gef proteins |
| 01/21/1999 | WO1999002675A1 G-coupled receptor showing selective affinity for atp |
| 01/21/1999 | WO1999002674A1 Peptides containing the motif igd and their use as cell migration modulators |
| 01/21/1999 | WO1999002672A1 Determination of genetic sex in equine species by analysis of y-chromosomal dna sequences |
| 01/21/1999 | WO1999002670A1 Method of attenuating pathogenic mycobacteria and strains of mycobacteria so attenuated |
| 01/21/1999 | WO1999002667A1 Mutations in the myostation gene cause double-muscling in mammals |
| 01/21/1999 | WO1999002666A2 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 01/21/1999 | WO1999002658A1 Inhibiting apoptosis with adenovirus rid protein |
| 01/21/1999 | WO1999002657A1 Rhabdoviruses with reengineered coats |
| 01/21/1999 | WO1999002653A1 Nucleic acid encoding a novel chemotherapy-induced protein, and methods of use |
| 01/21/1999 | WO1999002652A1 Transgenic nematode model of triplet repeat neurological diseases |
| 01/21/1999 | WO1999002566A2 Standardised protein |
| 01/21/1999 | WO1999002563A1 Ligand for herpes simplex virus entry mediator and methods of use |
| 01/21/1999 | WO1999002562A1 Isolated dendritic cell membrane protein genes |
| 01/21/1999 | WO1999002561A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation |
| 01/21/1999 | WO1999002560A1 Hoqbq59 |
| 01/21/1999 | WO1999002559A1 Reagents and methods useful for detecting diseases of the breast |
| 01/21/1999 | WO1999002558A1 Novel pharmaceutically active compounds interacting with gtp-binding proteins |
| 01/21/1999 | WO1999002557A1 Novel pharmaceutically active compounds interacting with gtp-binding proteins |
| 01/21/1999 | WO1999002556A1 Semaphorin receptors |
| 01/21/1999 | WO1999002555A1 Novel bacteriocins, transport and vector system and method of use thereof |
| 01/21/1999 | WO1999002554A2 Human herpesvirus-7 diagnostic and immunologic reagents and use thereof |
| 01/21/1999 | WO1999002553A1 Serum immunoregulatory polypeptides and uses therefor |
| 01/21/1999 | WO1999002552A2 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 01/21/1999 | WO1999002551A1 Integrin binding peptide and use thereof |
| 01/21/1999 | WO1999002550A1 Ctl epitopes from ebv |
| 01/21/1999 | WO1999002548A1 A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
| 01/21/1999 | WO1999002547A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 01/21/1999 | WO1999002546A1 123 human secreted proteins |
| 01/21/1999 | WO1999002192A1 Method of inducing apoptosis by reducing the level of thiamin |
| 01/21/1999 | WO1999002185A1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/21/1999 | WO1999002183A2 A method of inducing a ctl response |
| 01/21/1999 | WO1999002179A1 Axin gene and uses thereof |
| 01/21/1999 | WO1999002178A1 Therapeutic agent for the treatment of septicaemia, its preparation and use |
| 01/21/1999 | WO1999002175A1 Conjugates useful in the treatment of prostate cancer |
| 01/21/1999 | WO1999002171A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 01/21/1999 | WO1998049312A3 Nucleic acids, proteins, and methods of use of granulocytic erhlichia |
| 01/21/1999 | WO1998048025A3 Regulatory system for inducible expression of genes with lambdoid promoters |
| 01/21/1999 | WO1998048020A3 Mammalian ubiquitin-isopeptidases that control cell proliferation |
| 01/21/1999 | WO1998047913A3 Inhibition of hiv-1 replication by a tat rna-binding domain peptide analog |
| 01/21/1999 | WO1998046781A3 Novel transgene expression system for increased persistence |
| 01/21/1999 | WO1998046742A3 Dictyocaulus viviparus antigen for the diagnosis of lungworm disease and for vaccination |
| 01/21/1999 | WO1998046640A3 Methods and compositions for inducing immunosuppression |
| 01/21/1999 | WO1998043657A3 Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same |
| 01/21/1999 | WO1998031389A3 Fibronectin binding protein compositions, antibodies thereto, and methods of use |
| 01/21/1999 | WO1998024810A3 Vertebrate homologues of unc-53 protein of c. elegans |
| 01/21/1999 | DE19730786A1 New human neutrophil-lymphocyte peptide and its fragments |
| 01/21/1999 | DE19730535A1 Spezielle Virus-DNA-Fragmente und ihre Verwendung als Promotor Virus specific DNA fragments and their use as promoter |
| 01/21/1999 | CA2715850A1 Isolated dendritic cell membrane protein genes |
| 01/21/1999 | CA2659180A1 Trichoderma reesei swollenin protein and encoding dna sequences |
| 01/21/1999 | CA2332636A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 01/21/1999 | CA2298834A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 01/21/1999 | CA2296434A1 Mutations in the myostatin gene cause double-muscling in mammals |
| 01/21/1999 | CA2296093A1 Modified lepidopteran receptors and hybrid multifunctional proteins for use in regulation of transgene expression |
| 01/21/1999 | CA2296084A1 Increased production of secreted proteins by recombinant yeast cells |
| 01/21/1999 | CA2296071A1 Production and use of recombinant protein multimers with altered biological activity |
| 01/21/1999 | CA2296068A1 Novel bacteriocins, transport and vector system and method of use thereof |
| 01/21/1999 | CA2296046A1 Chimeric gene coding for drosomicine, vector containing it and production of transgenic plants resistant to diseases |
| 01/21/1999 | CA2295935A1 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 01/21/1999 | CA2295908A1 New human growth regulator protein |
| 01/21/1999 | CA2295860A1 Conjugates useful in the treatment of prostate cancer |
| 01/21/1999 | CA2295539A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 01/21/1999 | CA2295474A1 123 human secreted proteins |
| 01/21/1999 | CA2295320A1 Coffee storage proteins |
| 01/21/1999 | CA2295202A1 Method of increasing the iron content of plant cells |
| 01/21/1999 | CA2295149A1 Fusion proteins with an immunoglobulin hinge region linker |
| 01/21/1999 | CA2295086A1 Wa545 compositions |
| 01/21/1999 | CA2294732A1 Ctl epitopes from ebv |
| 01/21/1999 | CA2292843A1 Reagents and methods useful for detecting diseases of the breast |
| 01/21/1999 | CA2292791A1 Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein |
| 01/21/1999 | CA2290716A1 Fusion proteins comprising coiled-coil structures |
| 01/21/1999 | CA2263947A1 Enhanced expression of proteolytic enzymes in koji mold |
| 01/20/1999 | EP0892061A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratB |
| 01/20/1999 | EP0892059A2 Histidine kinase polypeptides |
| 01/20/1999 | EP0892057A2 Response regulator |
| 01/20/1999 | EP0892056A2 GidA1 polypeptides from Chlamydia trachomitis |
| 01/20/1999 | EP0892055A2 GidB polypeptides from Staphylococcus aureus |
| 01/20/1999 | EP0892054A1 Clostridium perfringens vaccine |
| 01/20/1999 | EP0892053A2 production of recombinant HPMBQ91 polypeptide and uses thereof |
| 01/20/1999 | EP0892052A1 Sodium-bicarbonate transporter polypeptides |
| 01/20/1999 | EP0892051A2 CDNA Clone heoad54 that encodes a human 7 transmembrane receptor |
| 01/20/1999 | EP0892050A2 Human HFIZG53 |
| 01/20/1999 | EP0892049A2 A human pelota homolog |
| 01/20/1999 | EP0892048A2 XAF genes and polypeptides and their use for modulating apoptosis |
| 01/20/1999 | EP0892047A2 Human and murine semaphorin L |
| 01/20/1999 | EP0892046A2 Melatonin-receptor expression cells and their uses |
| 01/20/1999 | EP0892045A2 Process for the production of a preparation containing hyaluronidase |
| 01/20/1999 | EP0891985A1 Process for the production of biologically active protein (e.g. TGF) |